SR
Sirona Biochem Corp.
SRBCF · OTC
$0.01 +0.00% (+$0.00)
Market Cap $2.29M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 65.77x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 30.97%
Book val. growth N/A
EPS growth N/A
Profitability
0 /100
Weak Op. margin 6,917.60%
Gross margin 82.71%
FCF margin 5,053.37%
Quality
58 /100
Average Asset turnover 0.03x
ROIC 1,259.21%
ROA 246.42%
Debt
4 /100
High Int. coverage -11.62x
Current ratio 0.55x
Debt/Assets N/A
Stability
25 /100
Unstable EPS volatility 49.40%
Beta -0.07x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SRBCF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Howard J. Verrico
Employees
10
Headquarters
Vancouver